1. Shou DW, Li YR, Xu XJ, et al. (2023): Parthenolide attenuates sepsis-induced acute kidney injury in rats by reducing inflammation. Evid Based Complement Alternat Med 2023: 8759766.
2.
Kellum JA, Formeck CL, Kernan KF, et al. (2022): Subtypes and mimics of sepsis. Crit Care Clin 38: 195-211.
3.
Bai Y, Li L, Dong B, et al. (2022): Phosphorylation-mediated PI3K-Art signalling pathway as a therapeutic mechanism in the hydrogen-induced alleviation of brain injury in septic mice. J Cell Mol Med 26: 5713-5727.
4.
Jacobi J (2022): The pathophysiology of sepsis – 2021 update: Part 2, organ dysfunction and assessment. Am J Health Syst Pharm 79: 424-436.
5.
Zhu D, Luo L, Zeng H, et al. (2023): Knockdown of 11-hydroxysteroid dehydrogenase type 1 alleviates LPS-induced myocardial dysfunction through the AMPK/SIRT1/PGC-1 pathway. J Biomed Res 37: 303-314.
6.
Wang S, Jia D, Lu H, et al. (2021): Paeoniflorin improves myocardial injury via p38 MAPK/NF-KB p65 inhibition in lipopolysaccharide-induced mouse. Ann Transl Med 9: 1449.
7.
Deng C, Liu Q, Zhao H, et al. (2023): Activation of NR1H3 attenuates the severity of septic myocardial injury by inhibiting NLRP3 inflammasome. Bioeng Transl Med 8: e10517.
8.
Zhang X, Cui Y, Ding X, et al. (2021): Analysis of mRNA lncRNA and mRNA lncRNA-pathway co expression networks based on WGCNA in developing pediatric sepsis. Bioengineered 12: 1457-1470.
9.
Wang SM, Liu GQ, Xian HB, et al. (2019): LncRNA NEAT1 alleviates sepsis-induced myocardial injury by regulating the TLR2/NF-B signaling pathway. Eur Rev Med Pharmacol Sci 23: 4898-4907.
10.
Wang J, Feng Q, Wu Y, et al. (2022): Involvement of blood lncRNA UCA1 in sepsis development and prognosis, and its correlation with multiple inflammatory cytokines. J Clin Lab Anal 36: e24392.
11.
Zhu L, Shi D, Cao J, et al. (2022): LncRNA CASC2 alleviates sepsis-induced acute lung injury by regulating the miR-152-3p/PDK4 Axis. Immunol Invest 51: 1257-1271.
12.
Sun F, Yuan W, Wu H, et al. (2020): LncRNA KCNQ1OT1 attenuates sepsis-induced myocardial injury via regulating miR-192-5p/XIAP axis. Exp Biol Med (Maywood) 245: 620-630.
13.
Pei X, Wu Y, Yu H, et al. (2022): Protective role of lncRNA TTN-AS1 in sepsis-induced myocardial injury via miR-29a/E2F2 axis. Cardiovasc Drugs Ther 36: 399-412.
14.
Wu X, Yin S, Yan L, et al. (2022): lncRNA DLEU1 modulates proliferation, inflammation, and extracellular matrix degradation of chondrocytes through regulating miR-671-5p. J Immunol Res 2022: 1816217.
15.
Li Z, Li A, Yan L, et al. (2020): Downregulation of long noncoding RNA DLEU1 attenuates hypersensitivity in chronic constriction injury-induced neuropathic pain in rats by targeting miR-133a-3p/SRPK1 axis. Mol Med 26: 104.
16.
Purcarea A, Sovaila S (2020): Sepsis, a 2020 review for the internist. Rom J Intern Med 58: 129-137.
17.
Ma D, Qin X, Zhong ZA, et al. (2022): Systematic analysis of myocardial immune progression in septic cardiomyopathy: Immune-related mechanisms in septic cardiomyopathy. Front Cardiovasc Med 9: 1036928.
18.
Luxen M, van Meurs M, Molema G (2022): Unlocking the untapped potential of endothelial kinase and phosphatase involvement in sepsis for drug treatment design. Front Immunol 13: 867625.
19.
Su J, Wu S, Zhou F, et al. (2023): Research progress of macromolecules in the prevention and treatment of sepsis. Int J Mol Sci 24: 13017.
20.
Xin T, Lu C (2020): SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury. Aging (Albany NY) 12: 16224-16237.
21.
Guo X, Qin Y, Wang L, et al. (2021): A competing endogenous RNA network reveals key lncRNAs associated with sepsis. Mol Genet Genomic Med 9: e1557.
22.
Zhang T, Yang YH, Liu YP, et al. (2022): Regulatory role of noncoding rna in sepsis and sepsis-associated organ dysfunction: an updated systematic review. Shock 58: 434-456.
23.
Wang Y, Xu Z, Yue D, et al. (2020): Linkage of lncRNA CRNDE sponging miR-181a-5p with aggravated inflammation underlying sepsis. Innate Immun 26: 152-161.
24.
Xiao T, Sun C, Xiao Y, et al. (2020): lncRNA NEAT1 mediates sepsis progression by regulating Irak2 via sponging miR-370-3p. Biol Open 9: bio049353.
25.
Yang M, Gu Y (2023): LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p. Ir J Med Sci 193: 241-247.
26.
Jia J, Guo S, Zhang D, et al. (2020): Exosomal-lncRNA DLEU1 accelerates the proliferation, migration, and invasion of endometrial carcinoma cells by regulating microRNA-E2F3. Onco Targets Ther 13: 8651-8663.
27.
Li H, Huang J, Yu S, et al. (2020): Long non-coding RNA DLEU1 up-regulates BIRC6 expression by competitively sponging miR-381-3p to promote cisplatin resistance in nasopharyngeal carcinoma. Onco Targets Ther 13: 2037-2045.
28.
Chen D, Hou Y, Cai X (2021): MiR-210-3p enhances cardiomyocyte apoptosis and mitochondrial dysfunction by targeting the NDUFA4 gene in sepsis-induced myocardial dysfunction. Int Heart J 62: 636-646.
29.
Gao L, Zhai Z, Shi Q, et al. (2022): MiR-501-5p alleviates cardiac dysfunction in septic patients through targeting NR4A3 to prevent its binding with Bcl-2. Cell Cycle 21: 961-971.
30.
Sang Z, Zhang P, Wei Y, et al. (2020): miR-214-3p attenuates sepsis-induced myocardial dysfunction in mice by inhibiting autophagy through PTEN/AKT/mTOR pathway. Biomed Res Int 2020: 1409038.
31.
Liu J, Yang Y, Lu R, et al. (2021): MicroRNA-381-3p signatures as a diagnostic marker in patients with sepsis and modulates sepsis-steered cardiac damage and inflammation by binding HMGB1. Bioengineered 12: 11936-11946.
